International Journal of STD & AIDS · 1998 · 35 citations · 0 references
MedicineCardiologyPharmacotherapyCardiovascular PharmacotherapyClinical CardiologyAntiretroviral TherapyCardiovascular DiseaseCoronary Artery DiseaseDyslipidemia ManagementIschemic Heart DiseaseMetabolic SyndromeCoronary Artery Disease PharmacotherapyPremature Coronary Artery DiseaseProtease InhibitionProtease InhibitorsProtease TherapyViral Protease Inhibition
Protease inhibitors are increasingly recognized as causing significant metabolic abnormalities including hypertriglyceridaemia, hypercholesterolaemia, insulin resistance, diabetes, and lipodystrophy. Considerable concern has been generated by recent reports of premature coronary artery disease occurring in HIV-1 infected patients on protease inhibitor containing regimens.